Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Clinical and Experimental Dermatology|January 5, 2017
Innate immunity in cutaneous melanomaC Mignogna, E Scali, C Camastra, et al.
The Journal of Cardiovascular Surgery|June 16, 2005
Carotid endarterectomy in heart transplant patientsM Porcellini, F P D'Armiento, D Di Lella, et al.
Histopathology|June 5, 2007
Chromatin assembly factor-1 (CAF-1)-mediated regulation of cell proliferation and DNA repair: a link with the biological behaviour of squamous cell carcinoma of the tongue?S Staibano, C Mignogna, L Lo Muzio, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 22, 2007
A case of mesonephric adenocarcinoma of the vagina with a 1-year follow-upG Bifulco, V D Mandato, C Mignogna, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 23, 2004
Expression of proto-oncogene c-kit in high risk prostate cancerG Di Lorenzo, R Autorino, F P D'Armiento, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|October 26, 2005
Neuroendocrine differentiation after neoadjuvant hormonal treatment in prostate cancerR Autorino, G Di Lorenzo, F P D'Armiento, et al.
BMC Neurology|August 10, 2016
Non-invasive real-time biopsy of intracranial lesions using short time expanded circulating tumor cells on glass slide: report of two casesN Malara, G Guzzi, C Mignogna, et al.
Prostate Cancer and Prostatic Diseases|January 19, 2005
Expression of biomarkers modulating prostate cancer progression: implications in the treatment of the diseaseG Di Lorenzo, S De Placido, R Autorino, et al.
International Journal of Immunopathology and Pharmacology|February 9, 2005
Squamous cell carcinoma of the lower lip: FAS/FASL expression, lymphocyte subtypes and outcomeP Somma, L Lo Muzio, G Mansueto, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2025
Association of peripheral monocytic myeloid-derived suppressor cells with molecular subtypes in single-center endometrial cancer patients receiving carboplatin + paclitaxel/avelumab (MITO-END3 trial)C D'Alterio, G Rea, M Napolitano, et al.
Pageof 3